Diabetes in a high secure hospital.
OBJECTIVE
To determine the prevalence of diabetes mellitus and its possible causes and to assess its control in a high secure hospital.


METHODS
A cross sectional survey and a prospective cohort study were conducted. The cross sectional survey included 408 patients admitted under the Mental Health Act, and the prospective study included 22 patients with known diabetes followed up for 24 months. The outcome measures evaluated were drug treatment, status of microvascular and macrovascular complications, glycated haemoglobin, and body mass index.


RESULTS
In the cross sectional survey, 35 out of 408 patients (8.6%; 95% confidence interval 5.9% to 11.3%) had known diabetes, and all of these had type 2 diabetes. Obesity, cigarette smoking, schizophrenia, and antipsychotic drug use were frequent, and weight gain was common after hospital admission. Glycaemic control was variable, and, although a majority of patients were above recommended treatment targets, control remained stable over the follow up period.


CONCLUSIONS
Type 2 diabetes was common in this hospital. Both its prevalence and the suboptimal glycaemic control in some patients probably relate to sedentary life, dietary factors, smoking, and perhaps widespread use of antipsychotic drugs. However, regular multidisciplinary input enabled most patients to maintain relatively stable glycaemic control, with good control of blood pressure and lipids, at levels similar to those seen in community and hospital diabetic clinics. Further modification of lifestyle risk factors is probably needed to reduce the prevalence and impact of diabetes in this patient group.
MacFarlane
I A
IA
Department of Diabetes and Endocrinology, University Hospital Aintree, Liverpool, UK. ian.macfarlane@aht.nwest.nhs.uk
Gill
G V
GV
Finnegan
D
D
Pinkney
J
J
D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D004739:England / Q000453:epidemiology; D004812:Epidemiologic Methods; D005260:Female; D006760:Hospitalization; D006782:Hospitals, Special; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
D007004:Hypoglycemic Agents